Comparative Analysis of Pharmaceutical Companies on NASDAQ

Company Overview - Traws Pharma, Inc. (NASDAQ:TRAW) is currently trading at $1.61 with a target price of $0.73, indicating a potential downside of approximately -54.90% [1][4] - Imunon, Inc. (IMNN) is trading at $3.80 with a target price of $5.36, reflecting a growth potential of +41.18% [2][4] - Cocrystal Pharma, Inc. (COCP) is trading at $1.11 with a target price of $0.79, suggesting a growth potential of -28.68% [3] - Mustang Bio, Inc. (MBIO) trades at $1.09 with a target price of $0.97, resulting in a growth potential of -10.76% [3] Financial Metrics - Imunon, Inc. has a market cap of $9.58 million, despite a negative EPS of -12.53 and a P/E ratio of -0.68 [2] - Cocrystal Pharma, Inc. has a market cap of $11.38 million, with an EPS of -0.93 and a P/E ratio of -1.17 [3] - Mustang Bio, Inc. has a market cap of $7.96 million, an EPS of -6.71, and a P/E ratio of -3.44 [3]